On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.

20:02 12/11/2024

PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.

PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.

Jiangxi Fushine Pharmaceutical (300497.SZ) obtained GMP certification from the Brazilian National Health Surveillance Agency.

FOUNDER HOLD (00418) spent 39,200 Hong Kong dollars on November 26 to repurchase 42,000 shares.

Walvax Biotechnology (300142.SZ) subsidiary received 13-valent pneumococcal conjugate vaccine Egypt market license.

Jiangxi Fushine Pharmaceutical (300497.SZ) obtained GMP certification from the Brazilian National Health Surveillance Agency.

FOUNDER HOLD (00418) spent 39,200 Hong Kong dollars on November 26 to repurchase 42,000 shares.

Walvax Biotechnology (300142.SZ) subsidiary received 13-valent pneumococcal conjugate vaccine Egypt market license.